How the Emerging NAFLD-NASH Crisis Underscores the Urgent Need for Better Diagnostics

With NAFLD and NASH now affecting well over 1 billion people globally, the world needs better diagnostics to accurately detect liver disease in an affordable, easy-touse and safe manner.

Abstract
Non-Alcoholic Fatty Liver Disease (NAFLD) and its inflammatory stage, Non-Alcoholic SteatoHepatitis (NASH), are now a global healthcare crisis, and the facts should frighten patients, healthcare providers and insurance companies alike.